Pinehurst Radiation Oncology is categorized under Oncologists in Pinehurst, NC and active since 2008.
Pinehurst Radiation Oncology was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Stephen King at the company’s single location by writing to 155 Memorial Drive, Pinehurst, North Carolina NC 28374 or by phoning (910) 715-1056. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pinehurst Radiation Oncology |
| Contact Person: | Stephen King |
| Address: | 155 Memorial Drive, Pinehurst, North Carolina 28374 |
| Phone Number: | (910) 715-1056 |
| Website Address: | nccancercare.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Pinehurst Radiation Oncology was started in 2008 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephen King for inquiries that concern Pinehurst Radiation Oncology by calling the company number (910) 715-1056, as your correspondence is most welcome. Additionally, the physical location of the single location of Pinehurst Radiation Oncology can be found at the coordinates 35.206399,-79.458041 as well as the street address 155 Memorial Drive in Pinehurst, North Carolina 28374.
For its online presence, you may visit Pinehurst Radiation Oncology’s website at nccancercare.org and engage with its social media outlets through on Twitter and on Facebook.